HILDEN, Germany and GERMANTOWN, Maryland, May 3, 2012 /PRNewswire/ -- - QIAGEN expands Point of Need portfolio with unique AmniSureassay to detect

VENLO, The Netherlands, April 25, 2012 /PRNewswire/ -- - Net sales rise 12% (+13% CER) to $296.4 million, adjusted operating income advances 14% to $80.3 million and adjusted

GERMANTOWN, Maryland and HILDEN, Germany, March 15, 2012 /PRNewswire/ -- - U.S.

SHANGHAI and GUANGZHOU, China and HILDEN, Germany, March 8, 2012 /PRNewswire/ -- - Agreement will make HPV testing more widely available throughout China

HILDEN, Germany and GERMANTOWN, Maryland, January 10, 2012 /PRNewswire/ -- - Licenses diagnostic rights for ALK (anaplastic lymphoma kinase) gene, a